Gennex Laboratories
Gennex Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Gennex Laboratories
Start SIPGennex Laboratories Investment Rating
-
Master Rating:
-
Gennex Laboratories has an operating revenue of Rs. 65.60 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 10% is healthy, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 9% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 94 which is a GREAT score indicating consistency in earnings, a RS Rating of 54 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 18 | 14 | 19 | 14 | 20 |
| Operating Expenses Qtr Cr | 17 | 13 | 18 | 13 | 19 |
| Operating Profit Qtr Cr | 1 | 1 | 1 | 1 | 1 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 1 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 2 | 1 | 1 | 1 | 1 |
Gennex Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹6.6
- 50 Day
- ₹6.32
- 100 Day
- ₹6.2
- 200 Day
- ₹6.33
- 20 Day
- ₹6.64
- 50 Day
- ₹6.21
- 100 Day
- ₹5.97
- 200 Day
- ₹6.22
Gennex Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹6.94 |
| Second Resistance | ₹7.16 |
| Third Resistance | ₹7.3 |
| RSI | 60.97 |
| MFI | 77.52 |
| MACD Single Line | 0.17 |
| MACD | 0.16 |
| Support | |
|---|---|
| First Resistance | ₹6.58 |
| Second Resistance | ₹6.44 |
| Third Resistance | ₹6.22 |
Gennex Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 126,249 | 9,235,114 | 73.15 |
| Week | 262,105 | 20,121,785 | 76.77 |
| 1 Month | 231,456 | 19,159,943 | 82.78 |
| 6 Month | 370,295 | 30,564,131 | 82.54 |
Gennex Laboratories Result Highlights
Gennex Laboratories Synopsis
BSE-Medical-Diversified
Gennex Laboratories belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 65.10 Cr. and Equity Capital is Rs. 18.02 Cr. for the Year ended 31/03/2023. Gennex Laboratories Ltd. is a Public Limited Listed company incorporated on 29/03/1990 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230TG1990PLC011168 and registration number is 011168.| Market Cap | 97 |
| Sales | 65 |
| Shares in Float | 10.96 |
| No of funds | 1 |
| Yield |
| Book Value | 1.56 |
| U/D Vol ratio | 2.1 |
| LTDebt / Equity | |
| Alpha | 0.05 |
| Beta | 0.11 |
Gennex Laboratories
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Aug-22 |
|---|---|---|---|---|
| Promoters | 23.38% | 23.38% | 23.38% | 23.38% |
| Individual Investors | 63.27% | 63.41% | 63.42% | 61.37% |
| Others | 13.35% | 13.21% | 13.2% | 15.25% |
Gennex Laboratories Management
| Name | Designation |
|---|---|
| Mr. Arihant Baid | Chairman & Managing Director |
| Mr. T M Gopalakrishnan | Whole Time Director |
| Mr. A R R Pantulu | Non Executive Director |
| Mr. Y Ravinder Reddy | Independent Director |
| Mr. A S Nageswar Rao | Independent Director |
| Ms. Sadhana Bhansali | Independent Woman Director |
Gennex Laboratories Forecast
Price Estimates
Gennex Laboratories Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-30 | Audited Results | |
| 2023-04-20 | Others | |
| 2023-02-14 | Quarterly Results | |
| 2022-11-14 | Quarterly Results | |
| 2022-08-12 | Quarterly Results |
Gennex Laboratories FAQs
What is Share Price of Gennex Laboratories ?
Gennex Laboratories share price is ₹6 As on 06 June, 2023 | 07:33
What is the Market Cap of Gennex Laboratories ?
The Market Cap of Gennex Laboratories is ₹97.3 Cr As on 06 June, 2023 | 07:33
What is the P/E ratio of Gennex Laboratories ?
The P/E ratio of Gennex Laboratories is 19.8 As on 06 June, 2023 | 07:33
What is the PB ratio of Gennex Laboratories ?
The PB ratio of Gennex Laboratories is 1.1 As on 06 June, 2023 | 07:33